Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8+ T cells

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6148-6157

  Sauer, Kerstin A ^a   Maxeiner, Joachim H ^a   Karwot, Roman ^a   Scholtes, Petra ^a   Lehr, Hans A ^b   Birkenbach, Mark ^c   Blumberg, Richard S ^d   Finotto, Susetta ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 27; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE RECEPTOR; EBI3 PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL EXPANSION; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOSURVEILLANCE; KILLER CELL; LUNG METASTASIS; LUNG MODEL; LUNG TUMOR; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL TRANSFORMATION; CYTOTOXICITY; EXPERIMENTAL MELANOMA; GENE INACTIVATION; GENETICS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METASTASIS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOTOXICITY, IMMUNOLOGIC; GENE KNOCKOUT TECHNIQUES; IMMUNOLOGIC SURVEILLANCE; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; RECEPTORS, CYTOKINE; T-BOX DOMAIN PROTEINS;

EID: 58749088415     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6148     Document Type: Article

References (33)

1. Gray-Schopfer, V., C. Wellbrock, and R. Marais. 2007. Melanoma biology and new targeted therapy. Nature 445: 851-857. (Pubitemid 46309849)
2. Neurath, M. F., S. Finotto, and L. H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8: 567-573. (Pubitemid 34633433)
3. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
4. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
5. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219. (Pubitemid 43214748)
6. Ullrich, E., M. Bonmort, G. Mignot, N. Chaput, J. Taieb, C. Menard, S. Viaud, T. Tursz, G. Kroemer, and L. Zitvogel. 2007. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells. Cancer Res. 67: 851-853. (Pubitemid 46270734)
7. Brombacher, F., R. A. Kastelein, and G. Alber. 2003. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24: 207-212. (Pubitemid 36412109)
8. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, A. C. Wakeham, H. Nishina, J. Potter, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15: 569-578. (Pubitemid 33016442)
9. Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170: 4886-4890. (Pubitemid 36554716)
10. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
11. Larousserie, F., E. Bardel, S. Pflanz, B. Arnulf, C. Lome-Maldonado, O. Hermine, L. Bregeaud, M. Perennec, N. Brousse, R. Kastelein, and O. Devergne. 2005. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am. J. Pathol. 166: 1217-1228. (Pubitemid 40524444)
12. Larousserie, F., E. Bardel, A. Coulomb L'Hermine, D. Canioni, N. Brousse, R. A. Kastelein, and O. Devergne. 2006. Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J. Pathol. 209: 360-368. (Pubitemid 43997745)
13. Wirtz, S., I. Tubbe, P. R. Galle, H. J. Schild, M. Birkenbach, R. S. Blumberg, and M. F. Neurath. 2006. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 203: 1875-1881. (Pubitemid 44188462)
14. Werneck, M. B., G. Lugo-Villarino, E. S. Hwang, H. Cantor, and L. H. Glimcher. 2008. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J. Immunol. 180: 8004-8010.
15. Maxeiner, J. H., R. Karwot, M. Hausding, K. A. Sauer, P. Scholtes, and S. Finotto. 2007. A method to enable the investigation of murine bronchial immune cells, their cytokines and mediators. Nat. Protoc. 2: 105-112.
16. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115: 313-325.
17. + T cells from murine lungs: a method to analyze ongoing immune responses in the lung. Nat. Protoc. 1: 2870-2875.
18. + cells from mice deficient in Epstein-Barr virus-induced gene 3 (EBI-3) prevent airway hyper-responsiveness in experimental asthma. Eur. J. Immunol. 37: 1663-1677.
19. + long-lived memory T cells in an allergy model. J. Allergy Clin. Immunol. 121: 992-999.e6.
20. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
21. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
22. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
23. Heath, W. R., G. T. Belz, G. M. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199: 9-26. (Pubitemid 38736761)
24. Shortman, K., and J. A. Villadangos. 2006. Is it a DC, is it an NK? No, it's an IKDC. Nat. Med. 12: 167-168.
25. Spits, H., and L. L. Lanier. 2007. Natural killer or dendritic: what's in a name? Immunity 26: 11-16. (Pubitemid 46109351)
26. + cells identify them as a subset of NK cells. J. Exp. Med. 204: 2561-2568.
27. + T cells. J. Immunol. 175: 7093-7097.
28. Caminschi, I., F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al. 2007. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204: 2579-2590. (Pubitemid 350044784)
29. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333. (Pubitemid 34461490)
30. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156: 25-37.
31. + T cells. Curr. Opin. Immunol. 15: 336-342.
32. Moretta, L., G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, M. C. Mingari, and A. Moretta. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 214: 219-228. (Pubitemid 44707913)
33. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100: 15818-15823.